Neoadjuvant Chemo-Immunotherapy for Locally Advanced Non-Small-Cell Lung Cancer: A Review of the Literature

Non-small cell lung cancer accounts for approximately 80–85% of all lung cancers and at present represents the main cause of cancer death among both men and women. To date, surgery represents the cornerstone; nevertheless, around 40% of completely resected patients develop disease recurrence. Theref...

Descripción completa

Detalles Bibliográficos
Autores principales: Franzi, Sara, Mattioni, Giovanni, Rijavec, Erika, Croci, Giorgio Alberto, Tosi, Davide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099888/
https://www.ncbi.nlm.nih.gov/pubmed/35566754
http://dx.doi.org/10.3390/jcm11092629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099888/
https://www.ncbi.nlm.nih.gov/pubmed/35566754
http://dx.doi.org/10.3390/jcm11092629

Ejemplares similares